The pharmaceutical and health products industry has been the top spender on lobbying so far in 2012, doling out nearly $70 million in the first quarter, according to the Center for Responsive Politics. The drug industry’s efforts have focused primarily on protecting existing provisions of Medicare Part D that subsidize prescription drug costs, but also […]